Patients with confirmed histological diagnosis Gleason scored (GS) of PCa, AJCC clinical stage T1 to T3a, with no evidence of metastatic disease and initial PSA <60mg/ml, prostate volume <60 cc measured by transrectal ultrasound (TRUS) suitable for EBRT and HDR under spinal anesthesia were eligible. Prior to treatment, patients